Physician profile
Anne E Harris
NPI 1619176500
$396.40
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $25.46 · 2021: $14.13 · 2022: $41.44 · 2023: $56.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $56.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $56.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $94.34 | 2019-2023 | Injectafer |
| Novo Nordisk INC | $54.34 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $39.71 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.10 | 2019-2020 | |
| Lilly USA, LLC | $19.05 | 2019 | |
| Medtronic, INC. | $17.56 | 2022 | |
| Astellas Pharma US INC | $16.22 | 2019 | |
| Sunovion Pharmaceuticals INC. | $15.42 | 2019 | |
| Emd Serono, INC. | $14.13 | 2021 | |
| Pfizer INC. | $13.32 | 2019 | |
| Amgen INC. | $12.88 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.83 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.77 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.37 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.